Search results
Melatonin Shows Promise in Reducing Macular Degeneration Risk
WebMD· 2 days agoBeyond their reputation as sleep aids, melatonin supplements might harbor a surprising potential: as a remedy for vision damage. In a study of more than 120,000 people ages 50 or older with ...
Ocular Therapeutix stock target and Market Perform rating held on axpaxli progress By Investing.com
Investing.com· 7 days agoThis affirmation follows the company's investor day, which provided updates on the clinical progress...
Clearside Biomedical announces board election results By Investing.com
Investing.com· 20 hours agoClearside Biomedical, Inc. (NASDAQ:CLSD), a pharmaceutical preparations company, reported the...
Outlook Therapeutics, Inc. (NASDAQ:OTLK) Short Interest Update
ETF DAILY NEWS· 4 days agoOutlook Therapeutics, Inc. (NASDAQ:OTLK – Get Free Report) was the target of a significant growth in short interest in the month of May. As of May 31st, there was short interest totalling 1,660,000 ...
REGENXBIO Inc. (NASDAQ:RGNX) Receives Consensus Recommendation of “Moderate Buy” from Analysts
ETF DAILY NEWS· 2 days agoShares of REGENXBIO Inc. (NASDAQ:RGNX – Get Free Report) have been assigned a consensus rating of “Moderate Buy” from the thirteen analysts that are covering the stock, Marketbeat.com reports ...
Oracle Alpha Inc. Buys New Stake in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)
ETF DAILY NEWS· 6 days agoOracle Alpha Inc. purchased a new position in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) during the fourth quarter, Holdings Channel reports. The fund purchased 693 ...
Teachers Retirement System of The State of Kentucky Sells 1,245 Shares of Regeneron Pharmaceuticals,...
ETF DAILY NEWS· 5 days agoTeachers Retirement System of The State of Kentucky cut its position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 6.7% during the 4th quarter, according to the company in ...
Regeneron Pharmaceuticals (NASDAQ:REGN) Sets New 52-Week High Following Analyst Upgrade
ETF DAILY NEWS· 4 days agoRegeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Get Free Report) shares reached a new 52-week high during mid-day trading on Monday after JPMorgan Chase & Co. raised their price target on the ...